PMID- 25750588 OWN - NLM STAT- PubMed-not-MEDLINE DCOM- 20150309 LR - 20220330 IS - 1477-9560 (Print) IS - 1477-9560 (Electronic) IS - 1477-9560 (Linking) VI - 12 DP - 2014 TI - Measurement of non-VKA oral anticoagulants versus classic ones: the appropriate use of hemostasis assays. PG - 24 LID - 10.1186/1477-9560-12-24 [doi] LID - 24 AB - Traditional anticoagulant agents such as vitamin K antagonists (VKAs), unfractionated heparin (UFH), low molecular weight heparins (LMWHs) and fondaparinux have been widely used in the prevention and treatment of thromboembolic diseases. However, these agents are associated with limitations, such as the need for regular coagulation monitoring (VKAs and UFH) or a parenteral route of administration (UFH, LMWHs and fondaparinux). Several non-VKA oral anticoagulants (NOACs) are now widely used in the prevention and treatment of thromboembolic diseases and in stroke prevention in non-valvular atrial fibrillation. Unlike VKAs, NOACs exhibit predictable pharmacokinetics and pharmacodynamics. They are therefore usually given at fixed doses without routine coagulation monitoring. However, in certain patient populations or special clinical circumstances, measurement of drug exposure may be useful, such as in suspected overdose, in patients experiencing a hemorrhagic or thromboembolic event during the treatment's period, in those with acute renal failure, in patients who require urgent surgery or in case of an invasive procedure. This article aims at providing guidance on laboratory testing of classic anticoagulants and NOACs. FAU - Douxfils, Jonathan AU - Douxfils J AD - Department of Pharmacy, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for LIfe Sciences (NARILIS), University of Namur, Namur, Belgium. FAU - Tamigniau, Anne AU - Tamigniau A AD - Hematology Laboratory, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for LIfe Sciences (NARILIS), CHU Dinant Godinne UcL Namur, Universite Catholique de Louvain, 1, avenue Dr Gaston Therasse, B5530 Yvoir, Belgium. FAU - Chatelain, Bernard AU - Chatelain B AD - Hematology Laboratory, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for LIfe Sciences (NARILIS), CHU Dinant Godinne UcL Namur, Universite Catholique de Louvain, 1, avenue Dr Gaston Therasse, B5530 Yvoir, Belgium. FAU - Goffinet, Catherine AU - Goffinet C AD - Clinique et Maternite Sainte-Elisabeth, Namur, Belgium. FAU - Dogne, Jean-Michel AU - Dogne JM AD - Department of Pharmacy, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for LIfe Sciences (NARILIS), University of Namur, Namur, Belgium. FAU - Mullier, Francois AU - Mullier F AD - Department of Pharmacy, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for LIfe Sciences (NARILIS), University of Namur, Namur, Belgium ; Hematology Laboratory, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for LIfe Sciences (NARILIS), CHU Dinant Godinne UcL Namur, Universite Catholique de Louvain, 1, avenue Dr Gaston Therasse, B5530 Yvoir, Belgium. LA - eng PT - Journal Article PT - Review DEP - 20141104 PL - England TA - Thromb J JT - Thrombosis journal JID - 101170542 PMC - PMC4351835 OTO - NOTNLM OT - Apixaban OT - Dabigatran OT - Enoxaparin OT - Low molecular weight heparin OT - Monitoring OT - Non-VKA oral anticoagulants OT - Rivaroxaban OT - Vitamin K antagonist EDAT- 2014/01/01 00:00 MHDA- 2014/01/01 00:01 PMCR- 2014/11/04 CRDT- 2015/03/10 06:00 PHST- 2014/03/11 00:00 [received] PHST- 2014/10/06 00:00 [accepted] PHST- 2015/03/10 06:00 [entrez] PHST- 2014/01/01 00:00 [pubmed] PHST- 2014/01/01 00:01 [medline] PHST- 2014/11/04 00:00 [pmc-release] AID - 215 [pii] AID - 10.1186/1477-9560-12-24 [doi] PST - epublish SO - Thromb J. 2014 Nov 4;12:24. doi: 10.1186/1477-9560-12-24. eCollection 2014.